Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
3(25%)
Results Posted
0%(0 trials)
Terminated
1(8%)

Phase Distribution

Ph not_applicable
9
75%
Ph phase_4
1
8%
Ph phase_3
1
8%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution11 total trials
Phase 3Large-scale testing
1(9.1%)
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
9(81.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

3

trials recruiting

Total Trials

12

all time

Status Distribution
Active(3)
Completed(4)
Terminated(2)
Other(3)

Detailed Status

Completed4
Recruiting3
unknown3
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
3
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (9.1%)
Phase 41 (9.1%)
N/A9 (81.8%)

Trials by Status

recruiting325%
terminated18%
completed433%
withdrawn18%
unknown325%

Recent Activity

Clinical Trials (12)

Showing 12 of 12 trials

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12